drugset / Trial / NCT00495508

Quinine vs. Artemether/Lumefantrine in Uncomplicated Malaria During Pregnancy

NCT00495508

RandomizedParallel-groupOpen-labelTreatment

Summary

A) for the treatment of uncomplicated malaria during second and third trimester pregnancy to oral Quinine hydrochloride. The PCR-corrected adequate clinical and parasitological response (ACPR) on day 42 is considered as the primary efficacy criterion. Newborns will be followed for growth and development indicators.

Timeline

Start
2006-10
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Artemether Small molecule 20 mg Oral
Comparator Quinine Small molecule 10 mg/kg Oral
Comparator lumefantrine Small molecule 120 mg Oral